Effektivnost' «S-E-T» - terapii na fone primeneniya neyropeptidov v rannem vosstanovitel'nom periode ishemicheskogo insul'ta


Cite item

Full Text

Abstract

Aim. To estimate the effectiveness of early rehabilitation in patients with severe impaired motor function after stroke with exercise (Sling Exercise complex) during treatment with the neuropeptide preparation Cortexine.
Material and methods. 3 group of patients after ischemic stroke with hemiparesis (severity from 1 to 3 points). All patients of groups 1 and 2, starting after 5 days of stroke, were carried out early physical training rehabilitation. The first group patients (n = 34) was used in the treatment with Cortexine 10mg i/m (course 15 days). The second group of patients (n = 36) neuropeptide drugs were not used. In the 3-d group (n = 30) physical rehabilitation is not carried out, neuropeptide drugs were not used.
Results. Early use of Physical rehabilitation techniques in patients after ischemic stroke vas safe and effective, and could improve the quality of life. Appointment in the first days of treatment of ischemic stroke neuropeptide drugs and the subsequent accession of exercise rehabilitation (Sling Exercise) increases the efficiency of complex mental and physical rehabilitation, in comparison with those patients in whom neuropeptide drugs and physical rehabilitation does not apply

References

  1. Виленский Б. С. Препараты нейротрофического действия в лечении инсульта. Качество жизни // Медицина. Болезни серд.-сосуд. системы.- 2003.- № 2.- С. 53-56.
  2. Даминов В. Д., Зимина Е. В., Уварова О.А., Кузнецов А.Н. Сочетанное применение функциональной стимуляции и роботизированной реконструкции ходьбы у больных в остром периоде ишемического инсульта // Вестник восстановительной Медицины.-2010.- №5.-С. 52 - 54.
  3. Daminov V.D., Rybalko N.V., Kuznetsov A.N. Central and cerebral blood flow estimation of patients in acute stroke applying tilt-table Erigo // European Journal of Physical and Rehabilitation Medicine.- 2010.- Vol. 46, Suppl. 1.- P. 2.
  4. Федин А. И., Румянцева С. А. Избранные вопросы базисной интенсивной терапии нарушений мозгового кровообращения. М.- 2002.- С. 6-30.
  5. Пептидная нейропротекция / под ред. М.М. Дьяконова, А.А. Каменского. - СПб.: Наука.- 2009. - 256 с.
  6. Bennett DA, Schneider JA, Arvanitakis Z. Neuropathology of older persons without cog- nitive impairment from two community-based studies. //Neurology.- 2006.-№66.- Р.1837-44.
  7. Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS).// Int J Epidemiol.- 2006.-№35.-Р.1140-5.
  8. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. // Stroke.- 2006.- №37.- Р. 2220-41.
  9. Шмырев В. И., Боброва Л. С, Боброва Т. А. Нейропротективная терапия в неврологической практике // Журн. «Кремлевская медицина». Клинический вестник.- 2003. -№ 2.- С. 36-39.
  10. Даминов В.Д. Мультидисциплинарный подход в ранней нейрореабилитации // Тезисы XI международной конференции «Современные технологии восстановительной медицины» - Сочи, 2010.-С. 78.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Arkhipov V.V., Privalov A.N., Poloyko A.A., Shestakov P.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies